Clinical Trials Logo

Lung Diseases clinical trials

View clinical trials related to Lung Diseases.

Filter by:

NCT ID: NCT05785195 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

A Mechanistic Study of Inhaled Nitric Oxide in COPD

Start date: March 14, 2023
Phase: N/A
Study type: Interventional

There is a lack of effective treatments for chronic obstructive pulmonary disease (COPD) complicated with pulmonary hypertension. Previous studies have found that inhaled nitric oxide (iNO) can reduce pulmonary artery pressure and improve exercise capacity in COPD with pulmonary hypertension patients. However, the specific mechanism is unclear. The study aims to evaluate pulmonary ventilation/perfusion, pulmonary artery pressure, oxygenation, symptoms and quality of life in COPD with pulmonary hypertension patients after short-term treatment with iNO. Observing a series of pathophysiological changes caused by the treatment of pulmonary hypertension with iNO in COPD, the investigators hope to provide new theoretical basis and research ideas.

NCT ID: NCT05785065 Not yet recruiting - Systemic Sclerosis Clinical Trials

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

SSc-mILD
Start date: December 2023
Phase: Phase 2
Study type: Interventional

The goal of this pilot study is to assess the feasibility of a larger study on the efficacy of mycophenolate mofetil in people diagnosed with systemic sclerosis with mild lung involvement. Participants will be recruited over 12 months at 3 academic centers and assigned randomly to receive either mycophenolate mofetil or placebo, a look-alike substance that contains no active drug, for 96 weeks.

NCT ID: NCT05784207 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical Doctors

Start date: June 1, 2017
Phase:
Study type: Observational

The purpose of this study is to compare AI performance to doctor's performance in the evaluation of IPF/UIP and ILDs without UIP(proven by biopsy).

NCT ID: NCT05781867 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Selective Manual Therapy Techniques in Chronic Obstructive Pulmonary Disease

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

Our study aiming for determining the combined effect of selective manual therapy techniques in chronic obstructive pulmonary disease patients

NCT ID: NCT05776654 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Wearable Devices in the Recovery Phase of Acute Exacerbations of COPD (AECOPDs)

Start date: February 16, 2023
Phase:
Study type: Observational

The purpose the study is to successfully characterize the recovery phase of acute exacerbations of COPD in the outpatient setting using remotely captured physiologic data from wearable devices, to compare this with patient self-reported symptom data, to determine which physiologic variable(s) best correspond with AECOPD recovery, and to further document the feasibility, data quantity, data quality, and COPD outpatient usability experience with wearable devices.

NCT ID: NCT05776264 Completed - Clinical trials for Chronic Lung Disease

Exercise Strategies to Motivate and Relieve Stress

Start date: March 29, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate exercise strategies that motivate and relive stress in adults with cardiopulomnary conditions. The goals of this study are as follows: - To explore the feasibility (how easily it can be done) of using self-selected music during exercise training for adults with cardiopulmonary conditions. - To assess patient satisfaction of self-selected music with exercise for adults with cardiopulmonary conditions. - To explore the immediate effects of self-selected music on mood and symptoms (shortness of breath and fatigue) compared with listening to a podcast during their exercise training session Participants will: - Select 5-7 songs and 1 podcast to listen to during their treatment session - Walk on the treadmill while either listening to a podcast or music - Fill out surveys about their mood, symptoms (shortness of breath and fatigue), music/podcast, and exercise

NCT ID: NCT05776225 Recruiting - Clinical trials for Pulmonary Hypertension

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

PHINDER
Start date: August 11, 2023
Phase:
Study type: Observational

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).

NCT ID: NCT05771766 Completed - Clinical trials for Lung Disease Chronic

Postural Drainage With and Without Aerobic Training on Chronic Suppurative Lung Disease

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

This will be a randomized controlled trial Patients will be divided into two groups randomly. Both groups will receive postural drainage as baseline treatment thrice a week for two weeks. The intervention group will undergo additional Aerobic Training thrice a week for two weeks as well along with postural drainage. Aerobic training will include a 5-step stair-climbing and a 10-step walk during each session. Data will be collected before and at the end of two weeks. Respiratory Rate, Pulse Oximeter, 10-meter Endurance walk test, and Pediatric Cough Questionnaire will be used to collect data pre and post-treatment. Data will be analyzed by use of SPSS Version 2010. Data will be presented in the form of mean and standard deviation.

NCT ID: NCT05771506 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Determinants of Balance in Patients With Chronic Obstructive Pulmonary Disease

Start date: January 1, 2023
Phase:
Study type: Observational

The primary aim of our study is to examine the relationship between balance and respiratory function, respiratory and peripheral muscle strength, functional capacity, and cognitive function in patients with Chronic Obstructive Pulmonary Disease (COPD). The secondary aim of our study is to compare respiratory function, respiratory and peripheral muscle strength, functional capacity, balance, and cognitive functions of COPD patients and healthy individuals. This study will examine and record the participant's sociodemographic information and medical records. Balance, respiratory function, respiratory and peripheral muscle strength, functional capacity, and cognitive function will be assessed. Since the patients are included in this study, no intervention will be made, no additional tests will be performed, or no changes will be made in the routine treatments of the patients during the study.

NCT ID: NCT05760508 Active, not recruiting - Clinical trials for Interstitial Lung Disease

Novel Markers of Disease Progression in Interstitial Lung Disease

NOMAD
Start date: July 23, 2018
Phase:
Study type: Observational

Study design: A prospective cohort study with a longitudinal design, with several parameters measured serially at baseline and at pre-specified time points during three to five years of clinical observation. Primary objective: To validate quantitative analysis of lung sounds as a marker of disease progression in a cohort of patients with Interstitial Lung Disease (ILD) via correlation with the extent of fibrosis on HRCT, measured both via visual scoring and quantitative CT assessment, and other validated parameters of disease progression such as FVC, tolerance to exercise and patient-related outcomes (symptoms and quality of life). Secondary objectives: To determine the prognostic value of quantitative analysis of lung sounds and a series of novel putative biological markers, obtained from peripheral blood and bronchoalveolar lavage, toward poor outcomes (death, categorical decline of % predicted FVC >10%, acute exacerbation or respiratory-related hospitalisations) as compared to more conventional clinical, physiology and radiologic measurements.